Literature DB >> 33742276

miR-106a-363 cluster in extracellular vesicles promotes endogenous myocardial repair via Notch3 pathway in ischemic heart injury.

Ji-Hye Jung1,2, Gentaro Ikeda1,2, Yuko Tada1,2, Daniel von Bornstädt3, Michelle R Santoso1, Christine Wahlquist2, Siyeon Rhee4, Young-Jun Jeon5, Anthony C Yu6, Connor G O'brien1, Kristy Red-Horse4, Eric A Appel6, Mark Mercola2, Joseph Woo3, Phillip C Yang7,8,9.   

Abstract

Endogenous capability of the post-mitotic human heart holds great promise to restore the injured myocardium. Recent evidence indicates that the extracellular vesicles (EVs) regulate cardiac homeostasis and regeneration. Here, we investigated the molecular mechanism of EVs for self-repair. We isolated EVs from human iPSC-derived cardiomyocytes (iCMs), which were exposed to hypoxic (hEVs) and normoxic conditions (nEVs), and examined their roles in in vitro and in vivo models of cardiac injury. hEV treatment significantly improved the viability of hypoxic iCMs in vitro and cardiac function of severely injured murine myocardium in vivo. Microarray analysis of the EVs revealed significantly enriched expression of the miR-106a-363 cluster (miR cluster) in hEVs vs. nEVs. This miR cluster preserved survival and contractility of hypoxia-injured iCMs and maintained murine left-ventricular (LV) chamber size, improved LV ejection fraction, and reduced myocardial fibrosis of the injured myocardium. RNA-Seq analysis identified Jag1-Notch3-Hes1 as a target intracellular pathway of the miR cluster. Moreover, the study found that the cell cycle activator and cytokinesis genes were significantly up-regulated in the iCMs treated with miR cluster and Notch3 siRNA. Together, these results suggested that the miR cluster in the EVs stimulated cardiomyocyte cell cycle re-entry by repressing Notch3 to induce cell proliferation and augment myocardial self-repair. The miR cluster may represent an effective therapeutic approach for ischemic cardiomyopathy.

Entities:  

Keywords:  Cell cycle re-entry; EVs; Endogenous cardiac repair mechanism; IPSCs; MiRNAs; Myocardial Infarction

Mesh:

Substances:

Year:  2021        PMID: 33742276      PMCID: PMC8601755          DOI: 10.1007/s00395-021-00858-8

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  62 in total

Review 1.  Emerging roles for E2F: beyond the G1/S transition and DNA replication.

Authors:  Hugh Cam; Brian David Dynlacht
Journal:  Cancer Cell       Date:  2003-04       Impact factor: 31.743

2.  Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells.

Authors:  S Bruno; Z Darzynkiewicz
Journal:  Cell Prolif       Date:  1992-01       Impact factor: 6.831

Review 3.  Cardiac myocyte cell cycle control in development, disease, and regeneration.

Authors:  Preeti Ahuja; Patima Sdek; W Robb MacLellan
Journal:  Physiol Rev       Date:  2007-04       Impact factor: 37.312

Review 4.  CDK inhibitors: cell cycle regulators and beyond.

Authors:  Arnaud Besson; Steven F Dowdy; James M Roberts
Journal:  Dev Cell       Date:  2008-02       Impact factor: 12.270

5.  Exosome/microvesicle-mediated epigenetic reprogramming of cells.

Authors:  Giovanni Camussi; Maria-Chiara Deregibus; Stefania Bruno; Cristina Grange; Valentina Fonsato; Ciro Tetta
Journal:  Am J Cancer Res       Date:  2010-10-22       Impact factor: 6.166

6.  MicroRNA-34a regulates cardiac ageing and function.

Authors:  Reinier A Boon; Kazuma Iekushi; Stefanie Lechner; Timon Seeger; Ariane Fischer; Susanne Heydt; David Kaluza; Karine Tréguer; Guillaume Carmona; Angelika Bonauer; Anton J G Horrevoets; Nathalie Didier; Zenawit Girmatsion; Peter Biliczki; Joachim R Ehrlich; Hugo A Katus; Oliver J Müller; Michael Potente; Andreas M Zeiher; Heiko Hermeking; Stefanie Dimmeler
Journal:  Nature       Date:  2013-02-20       Impact factor: 49.962

7.  Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury.

Authors:  Kevin Bersell; Shima Arab; Bernhard Haring; Bernhard Kühn
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

8.  MicroRNA regulation of a cancer network: consequences of the feedback loops involving miR-17-92, E2F, and Myc.

Authors:  Baltazar D Aguda; Yangjin Kim; Melissa G Piper-Hunter; Avner Friedman; Clay B Marsh
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-09       Impact factor: 11.205

9.  Clustering and conservation patterns of human microRNAs.

Authors:  Yael Altuvia; Pablo Landgraf; Gila Lithwick; Naama Elefant; Sébastien Pfeffer; Alexei Aravin; Michael J Brownstein; Thomas Tuschl; Hanah Margalit
Journal:  Nucleic Acids Res       Date:  2005-05-12       Impact factor: 16.971

10.  Self-assembled hydrogels utilizing polymer-nanoparticle interactions.

Authors:  Eric A Appel; Mark W Tibbitt; Matthew J Webber; Bradley A Mattix; Omid Veiseh; Robert Langer
Journal:  Nat Commun       Date:  2015-02-19       Impact factor: 14.919

View more
  13 in total

Review 1.  Extracellular vesicles in cardiovascular disease: Biological functions and therapeutic implications.

Authors:  Chaoshan Han; Junjie Yang; Jiacheng Sun; Gangjian Qin
Journal:  Pharmacol Ther       Date:  2021-10-20       Impact factor: 13.400

2.  Heterogeneous nuclear ribonucleoprotein U-actin complex derived from extracellular vesicles facilitates proliferation and migration of human coronary artery endothelial cells by promoting RNA polymerase II transcription.

Authors:  Han Wang; Hengdao Liu; Xi Zhao; Xiaowei Chen
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 3.  Signaling pathways and targeted therapy for myocardial infarction.

Authors:  Qing Zhang; Lu Wang; Shiqi Wang; Hongxin Cheng; Lin Xu; Gaiqin Pei; Yang Wang; Chenying Fu; Yangfu Jiang; Chengqi He; Quan Wei
Journal:  Signal Transduct Target Ther       Date:  2022-03-10

4.  Cardioprotection vs. regeneration: the case of extracellular vesicle-derived microRNAs.

Authors:  Kai C Wollert; Loren J Field
Journal:  Basic Res Cardiol       Date:  2021-03-19       Impact factor: 17.165

5.  Extracellular vesicles fail to trigger the generation of new cardiomyocytes in chronically infarcted hearts.

Authors:  Bruna Lima Correa; Nadia El Harane; Manon Desgres; Maria Perotto; Paul Alayrac; Chloé Guillas; Laetitia Pidial; Valérie Bellamy; Emilie Baron; Gwennhael Autret; Keirththana Kamaleswaran; Chloé Pezzana; Marie-Cécile Perier; José Vilar; Antonio Alberdi; Alain Brisson; Nisa Renault; Massimiliano Gnecchi; Jean-Sébastien Silvestre; Philippe Menasché
Journal:  Theranostics       Date:  2021-11-02       Impact factor: 11.556

Review 6.  Stem Cell and Exosome Therapy in Pulmonary Hypertension.

Authors:  Seyeon Oh; Ji-Hye Jung; Kyung-Jin Ahn; Albert Youngwoo Jang; Kyunghee Byun; Phillip C Yang; Wook-Jin Chung
Journal:  Korean Circ J       Date:  2022-02       Impact factor: 3.243

Review 7.  Plant-RNA in Extracellular Vesicles: The Secret of Cross-Kingdom Communication.

Authors:  Ornella Urzì; Roberta Gasparro; Nima Rabienezhad Ganji; Riccardo Alessandro; Stefania Raimondo
Journal:  Membranes (Basel)       Date:  2022-03-23

8.  Extracellular vesicle-packaged mitochondrial disturbing miRNA exacerbates cardiac injury during acute myocardial infarction.

Authors:  Ping Sun; Chao Wang; Ge Mang; Xiangli Xu; Shuai Fu; Jianfeng Chen; Xiaoqi Wang; Weiwei Wang; Hairu Li; Peng Zhao; Yifei Li; Qi Chen; Naixin Wang; Zhonghua Tong; Xin Fu; Ying Lang; Shasha Duan; Dongmei Liu; Maomao Zhang; Jiawei Tian
Journal:  Clin Transl Med       Date:  2022-04

Review 9.  The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years.

Authors:  Chan Wu; Binghong Liu; Ruiying Wang; Gang Li
Journal:  Front Cardiovasc Med       Date:  2022-01-17

10.  Systemic delivery of large-scale manufactured Wharton's Jelly mesenchymal stem cell-derived extracellular vesicles improves cardiac function after myocardial infarction.

Authors:  Michael A Bellio; Rosemeire M Kanashiro-Takeuchi; Lauro Takeuchi; Shathiyah Kulandavelu; Yee-Shuan Lee; Wayne Balkan; Karen C Young; Joshua M Hare; Aisha Khan
Journal:  J Cardiovasc Aging       Date:  2022-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.